Abstract
Background Ticagrelor and prasugrel are third-generation oral P2Y(12) receptor antagonists with rapid onset and pronounced platelet inhibition. Howeve......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
